<DOC>
	<DOCNO>NCT00106171</DOCNO>
	<brief_summary>It know anti-HIV treatment recently infect patient improve long-term patient prognosis . The purpose study determine one year course anti-HIV medication slow progression HIV disease adult recently infect HIV . Study hypothesis : A one-year course HAART administer acute early seroconversion may slow progression HIV infection .</brief_summary>
	<brief_title>Anti-HIV Medications People Recently Infected With HIV</brief_title>
	<detailed_description>Although doctor favor start anti-HIV treatment soon possible patient learn infect , know treatment recently infect patient result slow progression HIV disease . This study compare virologic outcome recently infect adult receive highly active antiretroviral therapy ( HAART ) receive treatment . This study also compare effect treatment patient enroll within 3 month seroconversion ( acute seroconverters ) patient enroll within 3 12 month seroconversion ( early seroconverters ) . This study last least 3 year . Participants randomly assign one two group . Group 1 receive HAART 1 year ; Group 2 receive treatment . There least 20 study visit 3-year study period . Blood collection occur study visit . A physical exam , medical medication history , risk behavior assessment occur visit ; participant also ask complete adherence questionnaire visit .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<criteria>Documented acute recent HIV infection ( infect past 12 month ) define study protocol Antiretroviral naive . Participants take antiretrovirals postexposure prophylaxis eligible study . Able swallow tablet capsule Willing use acceptable form contraception Physician unable design potentially effective HAART regimen base result genotypic resistance test Two CD4 count less 350 cells/mm3 obtain least 7 day apart within 30 day study entry Viral load le 5,000 copies/ml within 30 day study entry participant infect HIV1 six month prior study entry Use systemic cancer chemotherapy , systemic investigational agent , specific antiretroviral medication , immunomodulators ( growth factor , systemic corticosteroid , HIV vaccine , immune globulin , interleukin , interferon ) within 30 day prior study entry Current alcohol drug use , opinion investigator , would interfere study Serious illness require systemic treatment hospitalization participant either complete therapy clinically stable therapy least 7 day prior study entry Currently involuntarily incarcerate treatment either psychiatric physical ( e.g. , infectious disease ) illness Pregnancy breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>HIV</keyword>
	<keyword>Acute/Early Seroconverters</keyword>
	<keyword>Acute Infection</keyword>
	<keyword>Treatment Naive</keyword>
	<keyword>Primary HIV Infection</keyword>
</DOC>